From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
Over the last years <i>CFTR</i> (cystic fibrosis transmembrane conductance regulator) modulators have shown the ability to improve relevant clinical outcomes in patients with cystic fibrosis (CF). This review aims at a systematic research of the current evidence on efficacy and tolerabil...
Main Authors: | Andrea Gramegna, Martina Contarini, Stefano Aliberti, Rosaria Casciaro, Francesco Blasi, Carlo Castellani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/16/5882 |
Similar Items
-
Impact of <i>CFTR</i> Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
by: Aniello Meoli, et al.
Published: (2022-10-01) -
State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (<i>CFTR</i>) Modulators and Triple-Combination Therapy
by: Aniello Meoli, et al.
Published: (2021-09-01) -
Functional Consequences of CFTR Interactions in Cystic Fibrosis
by: Yashaswini Ramananda, et al.
Published: (2024-03-01) -
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
by: Caitlyn Harvey, et al.
Published: (2022-03-01) -
Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
by: Shiferaw D, et al.
Published: (2019-08-01)